MENU

ADXS Ayala Pharmaceuticals, Inc. Forecast, Technical & Fundamental Analysis

Ayala Pharmaceuticals Inc is a clinical-stage oncology company whose primary clinical assets currently include aspacytarabine (BST-236), a novel proprietary anti-metabolite for first-line treatment in unfit acute myeloid leukemia (AML)... Show more

Industry: #Biotechnology
Interact to see
Advertisement
View a ticker or compare two or three
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a developer of immunotherapies for cancer and infectious diseases

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
Oppenheimer 4
Phone
+972 8574440553
Employees
35
Web
https://www.ayalapharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA400.494.11
+1.04%
Tesla
SPY746.747.68
+1.04%
State Street® SPDR® S&P 500® ETF
BTC.X63540.836000644.363300
+1.02%
Bitcoin cryptocurrency
AAPL298.012.06
+0.70%
Apple
GME21.520.01
+0.05%
GameStop Corp
Ayala Pharmaceuticals (ADXS) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com